Melissa H.S. Roeffen

438 total citations
13 papers, 339 citations indexed

About

Melissa H.S. Roeffen is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Melissa H.S. Roeffen has authored 13 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Melissa H.S. Roeffen's work include Sarcoma Diagnosis and Treatment (10 papers), Lymphoma Diagnosis and Treatment (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Melissa H.S. Roeffen is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), Lymphoma Diagnosis and Treatment (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Melissa H.S. Roeffen collaborates with scholars based in Netherlands, United States and Australia. Melissa H.S. Roeffen's co-authors include Winette T.A. van der Graaf, Yvonne M.H. Versleijen‐Jonkers, Uta Flucke, Albert J.H. Suurmeijer, Eveline S.J.M. de Bont, Emmy D.G. Fleuren, Otto C. Boerman, Stefan Sleijfer, Annelies M. C. Mavinkurve‐Groothuis and H.W.B. Schreuder and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Melissa H.S. Roeffen

13 papers receiving 336 citations

Peers

Countries citing papers authored by Melissa H.S. Roeffen

Since Specialization

Citations

This map shows the geographic impact of Melissa H.S. Roeffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa H.S. Roeffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa H.S. Roeffen more than expected).

Fields of papers citing papers by Melissa H.S. Roeffen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa H.S. Roeffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa H.S. Roeffen. The network helps show where Melissa H.S. Roeffen may publish in the future.

Co-authorship network of co-authors of Melissa H.S. Roeffen

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa H.S. Roeffen. A scholar is included among the top collaborators of Melissa H.S. Roeffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa H.S. Roeffen. Melissa H.S. Roeffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models 2014 ·International Journal of Cancer ·Emmy D.G. Fleuren, Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Roeffen, Gerben M. Franssen, Uta Flucke, Peter J. Houghton, Wim J.G. Oyen, Otto C. Boerman, Winette T.A. van der Graaf	17
2	Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: A rational choice 2013 ·European Journal of Cancer ·(unknown), Melissa H.S. Roeffen, Uta Flucke, Jeroen van der Laak, (unknown), Eveline S.J.M. de Bont, Albert J.H. Suurmeijer, Yvonne M.H. Versleijen‐Jonkers, Winette T.A. van der Graaf	34
3	Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients 2013 ·Targeted Oncology ·Addy C.M. van de Luijtgaarden, Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Roeffen, H.W.B. Schreuder, Uta Flucke, Winette T.A. van der Graaf	19
4	The strength of small: Improved targeting of Insulin-like Growth Factor-1 Receptor (IGF-1R) with F(ab′)2-R1507 fragments in Ewing sarcomas 2013 ·European Journal of Cancer ·Emmy D.G. Fleuren, Yvonne M.H. Versleijen‐Jonkers, Sandra Heskamp, Melissa H.S. Roeffen, (unknown), Janneke D.M. Molkenboer‐Kuenen, Hanneke W.M. van Laarhoven, Wim J.G. Oyen, Otto C. Boerman, Winette T.A. van der Graaf	10
5	Abstract 2761: Temsirolimus is effective as a single agent and in combination with cisplatin or bevacizumab in preclinical osteosarcoma models. 2013 ·Cancer Research ·Emmy D.G. Fleuren, Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Roeffen, Gerben M. Franssen, Peter J. Houghton, Wim J.G. Oyen, Otto C. Boerman, Winette T.A. van der Graaf	3
6	IGF Signaling Pathway Analysis of Osteosarcomas Reveals the Prognostic Value of pAKT Localization 2013 ·Future Oncology ·Addy C.M. van de Luijtgaarden, Melissa H.S. Roeffen, (unknown), Uta Flucke, Bart Schreuder, Winette T.A. van der Graaf, Yvonne M.H. Versleijen‐Jonkers	7
7	αB-Crystallin Expression is Correlated with Phospho-ERK1/2 Expression in Human Breast Cancer 2013 ·The International Journal of Biological Markers ·(unknown), Freekje van Asten, Irıs D. Nagtegaal, Yvonne M.H. Versleijen‐Jonkers, Hanneke W.M. van Laarhoven, Melissa H.S. Roeffen, Fred C.G.J. Sweep, Johan Bussink, Johannes H.A.M. Kaanders, Ger J.M. Pruijn, Wilbert C. Boelens, Paul N. Span	3
8	Expression and clinical relevance of MET and ALK in Ewing sarcomas 2013 ·International Journal of Cancer ·Emmy D.G. Fleuren, Melissa H.S. Roeffen, William P. J. Leenders, Uta Flucke, Myrella Vlenterie, H.W.B. Schreuder, Otto C. Boerman, Winette T.A. van der Graaf, Yvonne M.H. Versleijen‐Jonkers	47
9	Simultaneous Targeting of the Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Anaplastic Lymphoma Kinase (ALK) in Embryonal and Alveolar Rhabdomyosarcoma 2012 ·Annals of Oncology ·(unknown), Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Roeffen, Uta Flucke, Geert J. M. G. van der Heijden, Albert J.H. Suurmeijer, Eveline S.J.M. de Bont, Winette T.A. van der Graaf	2
10	Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507 2011 ·Clinical Cancer Research ·Emmy D.G. Fleuren, Yvonne M.H. Versleijen‐Jonkers, Addy C.M. van de Luijtgaarden, Janneke D.M. Molkenboer‐Kuenen, Sandra Heskamp, Melissa H.S. Roeffen, Hanneke W.M. van Laarhoven, Peter J. Houghton, Wim J.G. Oyen, Otto C. Boerman, Winette T.A. van der Graaf	37
11	Anaplastic Lymphoma Kinase Aberrations in Rhabdomyosarcoma: Clinical and Prognostic Implications 2011 ·Journal of Clinical Oncology ·(unknown), Uta Flucke, Melissa H.S. Roeffen, Eveline S.J.M. de Bont, Stefan Sleijfer, Annelies M. C. Mavinkurve‐Groothuis, Albert J.H. Suurmeijer, Winette T.A. van der Graaf, Yvonne M.H. Versleijen‐Jonkers	92
12	Predicting an optimal strategy for insulin-like growth factor 1 (IGF1) signaling interference in Ewing's sarcoma (ES). 2010 ·Journal of Clinical Oncology ·(unknown), Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Roeffen, Uta Flucke, (unknown), Winette T.A. van der Graaf	2
13	Arts Syndrome Is Caused by Loss-of-Function Mutations in PRPS1 2007 ·The American Journal of Human Genetics ·Arjan P.M. de Brouwer, Kelly L. Williams, John A. Duley, André B. P. Kuilenburg, Sander B. Nabuurs, M. Egmont‐Petersen, Dorien Lugtenberg, Lida Zoetekouw, (unknown), Melissa H.S. Roeffen, Ben C.J. Hamel, Linda S. Weaving, Robert Ouvrier, Jennifer A. Donald, Ron A. Wevers, John Christodoulou, Hans van Bokhoven	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact